Ferring Group

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40012771

Informations générales

Localisation

Switzerland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

08/01/2026

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%
2015 (année de référence)2034
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target: Ferring Group commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Ferring Group commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2023 base year. Ferring Group also commits that 74% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2030. Long-Term Targets: Ferring Group commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2023 base year. Ferring Group also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, waste generated in operations, business travel and end-of-life treatment of sold products 90.0% within the same timeframe.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques